as 03-28-2025 4:00pm EST
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Founded: | 1956 | Country: | United States |
Employees: | N/A | City: | WALTHAM |
Market Cap: | 203.5B | IPO Year: | N/A |
Target Price: | $652.65 | AVG Volume (30 days): | 1.7M |
Analyst Decision: | Strong Buy | Number of Analysts: | 20 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 16.53 | EPS Growth: | 6.99 |
52 Week Low/High: | $493.30 - $627.88 | Next Earning Date: | 04-23-2025 |
Revenue: | $42,879,000,000 | Revenue Growth: | 0.05% |
Revenue Growth (this year): | 3.35% | Revenue Growth (next year): | 6.60% |
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Insider Monkey
5 days ago
GuruFocus.com
5 days ago
Insider Monkey
6 days ago
Benzinga
8 days ago
Zacks
9 days ago
Insider Monkey
9 days ago
Zacks
10 days ago
Zacks
11 days ago
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.